NYSE : CAH

Cardinal Health, Inc.

$228.03 USD

$2.05 (0.91%)

Volume
1.18M
Average Volume
2.44M
Market Capitalization
$53.41B
P/E Ratio
34.76
Dividend Yield
0.90%
Price Target
$255.50
Year High
$243.21
Year Low
$137.75
Day High
—
Day Low
—
Payout Ratio
$0.31
Current Ratio
$0.91
Company Overview

NYSE

Jason Hollar

Medical - Distribution

Healthcare

CAH

57700

US

USD

https://www.cardinalhealth.com

614 757 5000

14149Y108

0000721371

Liquidity Metrics

-3.15

0.91

0.48

0.09

0.31

Sales & Valuation

$222.58B

0.21

-18.92

12.16

18.69

Profitability

$6.45

$1.56B

0.62%

0.80%

-55.72%

2.75%

P/E Metrics

34.76

17.19

17.19

Analyst Price Target & Rating

$255.50

$275.00

$235.00

Sell

2/5

33 Analysts

-10.75%

Financial Health Scores

5.04

6/9

-$3.92B

$56.69B

$59.36B

$2.17B

Key Metrics (TTM)

$58.38B

0.23

19.29

0.91

-55.72%

11.62%

2.91%

8.22%

-10 days

Company Executives
Name Title
Deborah L. Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment
Jessica L. Mayer Chief Legal & Compliance Officer
Patricia English Senior Vice President
Craig Cowman President of Biopharma Solutions & Strategic Sourcing
Jason Hollar Chief Executive Officer & Director
Stephen Mason Chief Executive Officer of GMPD segment
Aaron E. Alt Chief Financial Officer
Matt Sims Vice President of Investor Relations
Mary C. Scherer Senior Vice President & Chief Accounting Officer
Valerie Christine Pitteroff Chief Human Resources Officer
Poll Results

No votes yet today — be the first to share your view!

About Cardinal Health, Inc. (NYSE:CAH) Stock

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, ... particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Cardinal Health Expands Home Care Business With Two Acquisitions

2026-07-22 13:21:10

CAH is set to buy two home-care businesses for about $360 million, expanding diabetes and urology reach while targeting first-year EPS accretion.

Should Value Investors Buy Cardinal Health (CAH) Stock?

2026-07-22 10:41:09

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why Cardinal Health (CAH) is a Strong Momentum Stock

2026-07-21 10:51:08

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note

2026-07-20 19:01:15

Cardinal Health (CAH) reached $225.75 at the closing of the latest trading day, reflecting a -1.21% change compared to its last close.

Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million

2026-07-20 17:23:46

Cardinal Health said on Monday it has agreed to buy AdaptHealth's diabetes health business and ​medical supply provider Strive Medical in separate deals ‌for about $360 million in total, expanding its home care business.

Cardinal Health expands home care business with two tuck-in acquisitions

2026-07-20 16:45:00

DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy. Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ: AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology.

Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why

2026-07-14 19:01:14

In the closing of the recent trading day, Cardinal Health (CAH) stood at $230.11, denoting a -1.52% move from the preceding trading day.

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry

2026-07-14 04:36:12

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.

Frequently Asked Questions

What is the current Cardinal Health, Inc. (CAH) stock price?

Cardinal Health, Inc.(NYSE:CAH) stock price is $228.03 in the last trading session. During the trading session, CAH stock reached the peak price of $243.21 while $137.75 was the lowest point it dropped to. The percentage change in CAH stock occurred in the recent session was 0.91% while the dollar amount for the price change in CAH stock was $2.05.

CAH's industry and sector of operation?

The NYSE listed CAH is part of Medical - Distribution industry that operates in the broader Healthcare sector.

Who are the executives of CAH?

Deborah L. Weitzman | Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment
Jessica L. Mayer | Chief Legal & Compliance Officer
Patricia English | Senior Vice President
Craig Cowman | President of Biopharma Solutions & Strategic Sourcing
Jason Hollar | Chief Executive Officer & Director

How many employees does CAH have?

Number of CAH employees currently stands at 57700. CAH operates from 7000 Cardinal Place, Dublin, OH 43017, US.

Link for CAH official website?

Official Website of CAH is: https://www.cardinalhealth.com

How do I contact CAH?

CAH could be contacted at phone #614 757 5000 and can also be accessed through its website. CAH operates from 7000 Cardinal Place, Dublin, OH 43017, US.

How many shares of CAH are traded daily?

The average number of CAH shares traded daily for last 3 months was 2.44M.

What is the market cap of CAH currently?

The market value of CAH currently stands at $53.41B with its latest stock price at $228.03